← FDA DRUG APPROVALS

FDA BLA · BLA761400

LYNOZYFIC

Sponsor: RENGENERON PHARMACEUTICALS, INC.

APPLICATION
BLA761400
TYPE
BLA
ORIGINAL APPROVAL
2025-07-02
LATEST ACTION
2025-07-02
ROUTE
INJECTION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LYNOZYFICPrescription
LINVOSELTAMAB-GCPT 5MG/2ML · SOLUTION · INJECTION

Approval history

2025-07-02Type 1 - New Molecular Entity · Original · priorityLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →